Now I have all the information I need. Let me construct the final consolidated review.

## Summary

This paper systematically compares three input paradigms (sequence-only, context-only, sequence+context) for using LLMs on protein function prediction tasks (molecular function, pathway involvement, subcellular localization). The "context" is derived from bioinformatics tools (InterProScan, BLASTp) and presented as structured text. Across 8 LLMs (4 specialized Sci-LLMs, 4 general-purpose), the paper finds that context-only generally outperforms sequence-only, and that adding sequence to context degrades performance for specialized Sci-LLMs. Additional analyses cover embedding quality, temporal robustness, efficiency, and wet-lab validation.

## Strengths

1. **Comprehensive multi-model comparison (Table 1, Section 5.1).** The paper evaluates 8 models × 3 input configurations on three task categories. This is a substantial empirical effort that yields practically useful information about how different LLMs handle protein inputs. The finding that context-only consistently outperforms sequence-only is well-supported across all models.

2. **Efficiency and cost analysis (Table 2, Section 5.5).** The paper provides concrete cost and speed comparisons (AWS pricing) showing the context-driven approach is dramatically cheaper and faster than running Evolla, while achieving higher accuracy. This practical dimension strengthens the paper's real-world relevance.

3. **Temporal robustness analysis (Figure 4, Section 5.4).** The 30-year temporal split analysis shows that the context-driven approach degrades more gracefully (slope −0.618) than Evolla (−0.923) for recently discovered proteins. This is a meaningful evaluation of generalization to novel biology.

4. **Layer-wise Evolla analysis (Figure 3, Section 5.3).** Tracing ARI degradation from encoder (0.945) through Q-Former (0.916) to LLM decoder (0.809) provides mechanistic evidence that semantic alignment is a bottleneck, consistent with the paper's framing.

## Weaknesses

### Major

1. **The central claim that raw sequence "consistently degrades performance" is contradicted by the paper's own data.**

   The abstract states: *"the inclusion of the raw sequence alongside its high-level context consistently degrades performance."* Section 5.1 similarly claims *"consistent performance degradation observed in the Sequence + Context configuration."*

   Table 1 shows this pattern is **not** uniform. Among the four general-purpose LLMs:
   - **DeepSeek-V3**: Seq+Context (86.03) > Context-Only (84.99) — sequence *improves* performance
   - **GPT-5**: Seq+Context (76.45) > Context-Only (75.76) — sequence *improves* performance
   - **Qwen3**: Seq+Context (85.90) > Context-Only (84.99) — sequence *improves* performance
   - **Gemini2.5 Pro**: Context-Only (87.19) > Seq+Context (86.98) — very small degradation (−0.21)

   So 3 of 4 general LLMs show the **opposite** pattern. Degradation is consistent only among specialized Sci-LLMs (Intern-S1, Evolla, NatureLM). This distinction is important but the paper treats the phenomenon as universal. The claim needs to be qualified to specialized models only.

2. **Contradiction between text and figure in wet-lab validation (Section 5.6, Figures 5–6).**

   Section 5.6 states: *"While Evolla (Figure 6) attains a reasonable 80.0% accuracy on Rhodopsin, it fails catastrophically on PETase."*

   However, Figure 6 caption reports:
   - Rhodopsin: **5.00% accuracy** (1/20 correct)
   - PETase: **83.78% accuracy** (31/37 correct)

   This is a factor-of-16 discrepancy for Rhodopsin (80% vs 5%), and the characterization of PETase as "fails catastrophically" (83.78%) is also inconsistent with the figure data. Either the text is wrong, the figure is wrong, or the evaluation is inconsistent. This is a concrete reporting error that undermines confidence in the wet-lab validation results.

### Minor

3. **The tokenization dilemma is asserted rather than tested directly.**

   The paper attributes performance differences between sequence and context inputs to the "tokenization dilemma" (weak representation from atomic tokenization; semantic misalignment from modality encoders). However, no experiment isolates tokenization as a controlling variable. The poor performance of sequence-as-language models (e.g., NatureLM at 6.82% sequence-only) could stem from architecture, pre-training data, scale, instruction tuning, or task suitability — not specifically tokenization. A comparison of different tokenization strategies (e.g., single-residue vs. k-mer vs. BPE) within the same model would be needed to support the claimed mechanism, but such experiments are absent.

4. **Benchmark design favors the context-driven approach.**

   The three tasks — molecular function, pathway involvement, subcellular localization — are exactly the kinds of properties that the bioinformatics tools used to generate context (InterProScan, BLASTp) are designed to predict. The "context" (GO terms, domain annotations from homologs) is functionally near ground-truth for many well-studied proteins. The comparison is between (a) an LLM receiving distilled, highly informative annotations and (b) an LLM receiving only the raw sequence from which it must infer everything. This asymmetry is a feature of the real-world setting but makes the "tokenization dilemma" framing less informative — the experiment primarily shows that curated bioinformatics annotations are more useful than raw sequences, which is expected.

5. **Embedding visualization analysis has circularity (Section 5.2).**

   The Adjusted Rand Index is computed against ground-truth clusters derived from MMseqs2 (sequence homology at 50% identity). The context embeddings come from textual descriptions produced by tools (BLASTp, InterProScan) that use homology-based inference. That these embeddings align well with homology-derived clusters is partly tautological — context text encodes functional categories correlated with the clustering criterion. The cross-model comparison (ARI values across NatureLM, Intern-S1, Evolla, and context embeddings) is still informative about representation quality, but the specific superiority of context ARI (0.958) should be interpreted with this circularity in mind.

6. **No statistical significance reported.**

   Table 1 reports point estimates without confidence intervals or significance tests. Given several small differences (e.g., Intern-S1: 86.15 vs 84.03; NatureLM: 39.50 vs 38.86; Gemini: 87.19 vs 86.98), it is unclear whether the observed degradations or improvements are meaningful.

### Trivial

- None that survived filtering.

## Nice-to-Haves

- **Direct test of tokenization:** An ablation comparing different tokenization strategies (single residue, k-mer, BPE) within the same model architecture on the same tasks would directly test the claimed dilemma.
- **Fairer baseline comparison:** A controlled comparison where context is corrupted or scrambled would help distinguish whether degradation from adding sequence is due to tokenization or simply input length/capacity effects.
- **When sequence helps:** The finding that sequence improves performance for 3/4 general LLMs is interesting but undiscussed. Investigating why — perhaps general LLMs have seen more protein mentions in pre-training, or handle conflicting signals better — could illuminate the conditions under which raw sequence is genuinely useful.

## Removed Points

These points were raised in the reviews but are excluded from the main weaknesses after verification against the paper:

- **"Figure 1 mentions MEME but the method uses InterProScan"** — The figure is illustrative of the pipeline concept, not a specification. Inconsequential presentation choice.
- **"Section 3 preliminaries are standard but not used meaningfully"** — Formal preliminaries help structure the paper; their not being deeply used in analysis is not unusual for an empirical paper.
- **"Efficiency comparison depends on hardware assumptions"** — The paper reports AWS on-demand pricing transparently; this is standard for practical cost analysis.
- **"NatureLM's low performance not discussed"** — While the paper could discuss this more, it's not a central claim; the paper focuses on the comparison pattern, not explaining NatureLM's absolute performance.
- **"Temporal analysis confounded by different base models"** — The paper explicitly notes using DeepSeek-V3 "to ensure a fair comparison against models with similar training data cut-off dates."
- **"The strength finder claimed Sequence+Context consistently underperforms Context-Only"** — This is factually incorrect for 3/4 general LLMs and is excluded from the strengths.

## Novel Insights

None beyond the paper's own contributions. The key empirical finding — that context-only outperforms sequence-based approaches for specialized Sci-LLMs, but general LLMs sometimes benefit from having both — is interesting but requires the qualifier noted in Weakness #1. The layer-wise ARI degradation in Evolla (Figure 3) is a useful diagnostic that the paper identifies correctly.

## Suggestions

1. Qualify the "consistently degrades" claim to specialized Sci-LLMs and discuss the different behavior of general-purpose LLMs.
2. Resolve the 80% vs 5% contradiction in the wet-lab validation — verify which numbers are correct and ensure text/figure agreement.
3. Add confidence intervals or significance tests to Table 1.
4. Re-frame the contribution away from the untested "tokenization dilemma" mechanism and toward the practical finding that tool-augmented LLMs currently outperform end-to-end sequence-interpreting Sci-LLMs for protein function prediction.
5. Add a controlled baseline where context is derived without homology-based tools (e.g., using only InterProScan's intrinsic feature analysis without BLASTp annotations) to better separate the contributions.

## Score and Decision

### Calibration Anchors

**Round 1 (Bracketing):**
| Anchor | Score | Comparison |
|--------|-------|------------|
| ProteinAdapter (jqx5XI4Yr3) | 3.40 | Weaker — narrower scope, single task |
| Comparing pLMs for phages (IEZjjDX0iC) | 3.00 | Weaker — narrower scope |
| Does your model understand genes? (GDDqq0w6rs) | 4.75 | Comparable — both are benchmarking studies comparing model types on biological tasks, but that paper has fewer reporting errors |
| BEND (uKB4cFNQFg) | 5.00 | Comparable — both benchmark biological LMs, BEND is more methodologically rigorous |
| DNALONGBENCH (opv67PpqLS) | 5.67 | Stronger — more comprehensive benchmark design |
| Protein Discovery with DJS (zMPHKOmQNb) | 8.00 | Much stronger — different tier of contribution |

Initial bracket: 3.5–5.5

**Round 2 (Narrowing):**
| Anchor | Score | Comparison |
|--------|-------|------------|
| Long-context Protein LM (Et0SIGDpP5) | 4.25 | Comparable — both have methodological overclaiming issues and missing comparisons |
| LLaPA (AK9uRqzLjt) | 4.75 | Slightly stronger — has concrete methodological contribution (EC number reformulation, retrieval) though also criticized for leakage and overclaiming |
| ProtIR (jsQPjIaNNh) | 5.25 | Stronger — has a proposed method (iterative refinement) with strong baselines; more reviews |
| NL2ProGPT (sFJr7okOBi) | 4.50 | Comparable — both propose frameworks for LLM+protein integration |

After Round 2, I place the paper at the lower end of the bracket (around 4.0) because of the concrete figure/text contradiction and the overclaiming issue, which are more severe than the issues in comparable papers at 4.5–5.25.

**Final score: 4.0**

This paper makes a practically useful empirical contribution but is undermined by two significant problems: (1) the central claim that raw sequence "consistently degrades" performance is contradicted by the paper's own data for 3 of 4 general-purpose LLMs; and (2) a concrete reporting error in the wet-lab validation (80% vs 5% accuracy discrepancy) undermines trust. The "tokenization dilemma" framing is engaging but not directly tested. The paper would benefit from major revisions to align claims with evidence and fix the reporting inconsistency.

MY FINAL SCORE: <score>4.0</score>
MY FINAL DECISION: <decision>Reject</decision>